Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A new topical finasteride gel using nanoparticles shows promise for safe and effective hair regrowth.

Facial care products are not linked to causing frontal fibrosing alopecia.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Frontal fibrosing alopecia can affect African men and may be underdiagnosed.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

Cellcurin serum significantly increased hair growth in people with androgenetic alopecia.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

RNA editing significantly affects hair growth and follicle cycling in the Tianzhu white yak.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The new skin patch with human matrix and antibiotic improves wound healing.

Finasteride helps female-pattern hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Editing the FGF5 gene in sheep increases fine wool growth.

Finasteride's solubility improves with native y-CDs, enhancing hair loss treatment and reducing side effects.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

The research improved understanding of yak hair growth to help use yak wool better.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Finasteride may negatively affect male fertility.

The new method for making Finasteride is cheaper and safer for large-scale production.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Hormonal therapies help treat female hair loss, but results are slow and vary.

The new microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.